To mimic DM status, individual contributions of the altered Vmax,CYP2C19, Vmax,CYP3A4, and CLint,CES1 as well as Kt,i to the pharmacokinetics of CLOP-AM and their integrated contribution were investigated using CAD patients as control. This evidence concerns the gene CES1 and diabetes mellitus.